Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 February 2025 | Story Vuyelwa Mbebe | Photo Supplied
Regional Committee SAACHS
The Kovsie Health staff members who also serve on the SAACHS regional committee: Shibashiba Moabelo, Riana Johnson, Sarien de Necker, Theresa de Vries, and Emmerencia Sibanda.

The University of the Free State (UFS) took centre stage at the annual South African Association of Campus Health Services (SAACHS) Conference, held at the Windmill Casino Conference Centre in Bloemfontein from 8 to 10 January 2025. 

The conference was themed ‘Student Centredness’ and brought together representatives from 22 higher education institutions to explore critical issues related to student health and wellness.

SAACHS is a national association comprising tertiary institutions that offer primary and occupational healthcare services on campuses across South Africa. This year’s conference covered a range of pressing topics, including HIV support for students, strategies to assist pregnant students, telehealth collaborations, caregiver self-care, student health-seeking behaviours, food insecurity, and best practices in campus health emergency medical services.

Sr Riana Johnson, Deputy Director of Kovsie Health and regional chair of the Free State and Northern Cape SAACHS committee, emphasised the impact of the UFS’s involvement. “The strong representation of UFS speakers highlighted the strides we have made in campus health services and the invaluable contributions our institution brings to these crucial discussions,” she said.

As key organisers, Johnson and her team – including Sr Sarien de Necker and colleagues from the UFS and the Central University of Technology (CUT) – were instrumental in securing speakers, selecting relevant topics, and managing conference logistics. Their efforts ensured the smooth running of an event that encouraged knowledge-sharing and collaboration among campus health professionals.

“The conference provided a vital platform for networking and exchanging ideas,” Johnson said. “UFS’s active participation helped strengthen partnerships with institutions such as the Department of Health and promoted shared solutions to student wellness challenges.”

She added that hosting the event underscored the UFS’s leadership in campus health and allowed other institutions to learn from its initiatives. Discussions and collaborations at the conference enhanced awareness campaigns and reinforced a collective commitment to student well-being.

Looking ahead, Johnson believes the insights gained will shape the future of Kovsie Health. “Exploring new health technologies and expanding student-centred health initiatives are among our top priorities,” she concluded. “The knowledge shared at this conference will undoubtedly influence how we evolve our services to meet the needs of our students more effectively.”

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept